Source: BioCity Blog

BioCity Blog Biology 2.0: Combining machine-learning, robotics and biology to deliver drug discovery of tomorrow

Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment BioCity client company, Intelligent OMICS, supported by Arctoris and Medicines Discovery Catapult, are applying artificial intelligence to find new disease ‘drivers’ and candidate drugs for lung cancer.... The post Biology 2.0: Combining machine-learning, robotics and biology to deliver drug discovery of tomorrow appeared first on BioCity.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Toby Reid's photo - CEO of BioCity

CEO

Toby Reid

CEO Approval Rating

97/100

Read more